Table 1.
Descriptive characteristics of the Progela and non-Progel cohorts
| Descriptor | Non-Progel (n = 92, 52.27%) | Progel (n = 84, 47.73%) | p valueb |
|---|---|---|---|
| Age, y | |||
| Median | 66.5 | 65.0 | 0.568 |
| Interquartile range | 60–71 | 55–71.5 | |
| Sex, no. (%) | |||
| Women | 47 (51.09) | 41 (48.81) | 0.763 |
| Men | 45 (48.91) | 43 (51.19) | |
| Diagnoses and History, no. (%) | |||
| History of radiation | 4 (4.44) | 4 (4.76) | > 0.99 |
| History of chemotherapy | 3 (3.33) | 5 (5.95) | 0.485 |
| History of thoracic surgery | 0 (0) | 3 (3.57) | 0.110 |
| History of DM type 2 | 25 (27.78) | 21 (25.00) | 0.678 |
| COPD | 12 (13.33) | 12 (14.29) | 0.856 |
| Indication for surgery, no. (%) | |||
| Interstitial lung disease | 32 (34.78) | 25 (29.76) | 0.477 |
| Nodule | 60 (65.22) | 59 (70.24) | |
| Surgeon, no. (%) | |||
| A | 6 (6.52) | 2 (2.38) | 0.078 |
| B | 9 (9.78) | 3 (3.57) | |
| C | 6 (6.52) | 2 (2.38) | |
| D | 71 (77.17) | 77 (91.67) | |
a
Progel Pleural Air Leak Sealant (CR Bard Inc, Warwick, RI).
b
Categorical p values calculated using χ2 or Fisher exact test; continuous p values calculated using Kruskal-Wallis test.
COPD = chronic obstructive pulmonary disease; DM = diabetes mellitus.